Hepatitis B antigen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hepatitis B antigen, covering 2008-04-25 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years [Phase 1]